· METHODS:EighteenNewZealandwhiterabbitswere dividedintothreetreatmentgroups (groups1to3)and differentintravitrealdosesofquinupristin/dalfopristin weretestedineachgroup.Therighteyewasinjected withthedrugandthelefteyereceivedintravitreal injectionof5%dextrosewaterandservedascontroleye. Thedosesdeliveredtoeachgroupwere0.1mg/0.1mL, 1mg/0.1mLand10mg/0.1mL.Simultaneous,bilateral, dark-adaptedelectroretinographyandclinicalimagesof botheyeswereobtainedinallgroupsbeforeinjection (baseline)andafter7,14,21and28d,followedby enucleationforhistologicalexamination.
· RESULTS:Subjectsinthegroup1showednosignsof toxicityintheelectroretinogramwhencomparedwith groups2and3(Kruskall-Wallistest, =0.000).Byday7, noelectricalresponsetolightstimuliwasrecordedinthe treatedeyesingroups2and3,consistentwithsevere damageduetoretinaltoxicity.Lightmicroscopyrevealed nosignificanthistopathologicalchangesinthegroup1, while rabbits in groups 2 and 3 had signs of granulomatousinflammationinmostcases.
· CONCLUSION:Intravitreal0.1mg/0.1mLdosesof quinupristin/dalfopristindonotleadtoelectroretinographic orhistologicalsignsofretinaltoxicitycomparedwith 1mg/0.1mLand10mg/0.1mLinthisrabbitmodel.
INTRODUCTION
A cuteendophthalmitisisoneofthemostchallenging complicationsinophthalmicsurgeryandportendsa poorvisualoutcome.Becauseofthedifficultyinobtaining effectiveantibioticlevelswithintheeye parenteralor oraldrugadministration,intravitrealinjectionstillremains themainstayoftherapy.Becauseofthecurrenthigh prevalenceofinfectionscausedby ,the treatmentofchoiceisvancomycinandceftazidimeinorder tocoverGram-negativebacteria;theseareadministeredwith orwithoutsteroids [1] .However,inmanycases,thistreatment isnolongereffectiveparticularlyasaresultoftheincreasing prevalenceofresistantbacteriafoundinclinicalpractice. Quinupristin/Dalfopristin(Q-D)(Synercid,DSMPharmaceuticals,Inc.,Greenville,NC,USA)isanoveldrugthat combinestwostreptogramins:quinupristin(aBstreptogramin) anddalfopristin(anAstreptogramin)ina30:70ratio;itis indicatedinthetreatmentofseriousinfectionscausedby multiresistantGram-positiveorganismsandexhibitsextended activity against vancomycin-resistant strainsof staphylococci [2] [3] [4] . Q-Dhasaminimuminhibitoryconcentration(MIC) 臆 1 滋g/mLin90%ofGram-positiveisolatesresistantto other drugs, including and andaprolongedantibioticeffect(up to10h) [2, 4] .Q-Dhasalsodemonstrated inhibitory activityofproinflammatorymediators,thuspossiblyaffecting immunomodulatoryactivity [5] . Thereareafewcasereportsintheliteratureinwhichtheuse ofintravitrealQ-Dhasresultedinafavorableoutcome withoutsideoculareffects [5] [6] . .Ina recentreview,thesusceptibility,inendophthalmitissamples ofbacterialisolates,toceftazidimeandvancomycinwas studiedandtheyconcludethattheystillremainthetherapyof choiceforthisentity [11] .Nevertheless,becauseofthecurrent highprevalenceofbacterialresistancetovancomycin,and ceftazidime,treatmentneedstobemodifiedbasedonclinical response. Novelantibioticssuchasmoxifloxacinandgatifloxacin, fourth-generationfluoroquinolones,haveenhancedactivity againstGram-positivebacteriawhileretainingpotentactivity againstmostGram-negativebacteria,butintravitrealsafety hasnotbeendemonstrated,andbacterialresistancewas demonstratedinocularsamples [13] [14] [15] . Althoughmanyeyesaresuccessfullytreatedwiththeuseof intravitrealantibiotics-particularlywhenpromptly administered-therearestillmanycasesthatdonotrespond adequatelyandhaveapoorvisualoutcome;thisispartlydue totheinflammatoryphenomenaoccurringinendophthalmitis thatarenotquelledbyintravitrealantibioticsalone.Thisis whysomebelievethattheuseofconcomitantintravitreal steroidsmightbebeneficial,althoughthistherapeutic approachisstillsomewhatcontroversial [16] . Q-Disastreptograminantibioticthatasidefromits antibacterialproperties.Ithasbeenshowntoinhibit proinflammatorymediatorssuchasIL-1琢,IL-1茁,IL-6and TNF-琢,suggestingapossibleassociatedimmunomodulatory activity [5] .Thesepropertiesmightbeofsomeadvantagewhen treatingGram-positivebacterial endophthalmitisversus conventionalintravitrealtherapy.Therehavebeenafew reportsofintravitrealQ-Dinhumans withbacterial endophthalmitisresultinginfavorableoutcomes [5] [6] . Hernandez-DaMota [6] reportedasuccessfulsinglecaseusing adoseof0.4mg/0.1mLandStroh [5] reportedtwosuccessful casesofendophthalmitiscausedbyvancomycin-resistant strains,treatedwithasimilardoseofQ-D.Thisisconsistent withthefindingsinthisstudy,wheredosesbelow1mg/0.1mL didnotleadtosignificanttoxiceffectsinthestudiedeyes. ERGshowednostatisticallysignificantdifferencesbetween theamplitudesoftheretinala-andb-wavesinrabbits injectedwithalowdoseofQ-D(group1)norincontrol eyes,2and4wkafterinjection.However,b-waveamplitude flatteningandevenatotallossofresponsewereobservedin groups2and3,reflectingretinaltoxicity.Alsotherewasa morepronouncedbandformationingroups2and3,which mightbeasignofinflammatoryreponseaswellastoxicity. Histologicalexaminationrevealednosignificantchangesusing dosesof0.1mg/0.1mL;however,granulomatousreactions wereobservedintheothertwogroups.Thesehistopathological findingscorrelatewiththeelectrophysiologyresultsinthe groupsondosesabove1mg/0.1mL. Retinaltoxicityprofileshavebeenconductedwithother novelantibiotics.Kernt [14] reportedthatdosesupto 150 滋gofmoxifloxacinadministeredinthevitreousdidnot damagedifferentretinalcells.Aydin [17] studyingthe intravitrealtoxicityofdoxycycline,foundthatthegroup treatedwiththeantibioticexhibitedsignificantdecreasesin theERGwithdosesrangingbetween250and2000 滋gper 0.1mL.NosignificantchangesintheERGwereobserved followingtheinjectionoflowerdoses [17] .Linezolid,apotent anti-staphylococcalantibiotic,issafeatadoseof30mgafter intravitrealadministration [18] .Daptomycinisreportedto induceatotallossofthephotoreceptorlayerwithdosesof 750 滋g,butdosesupto188 滋gdidnotinducedeleterious changesintheretina [19] .Comer [19] reportedthat intravitrealdaptomycindosesabove200 滋gresultedinERG abnormalities,whiledosesbetween75and188 滋gdidnot leadtochangesinthescotopicandphotopicwavesofthe ERG;moderatedepressionwasexhibitedinthe375 滋gdose range,andseveredepressionresultedwiththe750 滋gdose. Thisstudyhasnumerouslimitationsthatmustbeconsidered. Thesmallnumberofanimalsused(6foreachgroup)could maskapossiblerealdifference(type2statisticalerror).Since nostatisticallysignificantdifferenceinelectroretinographic activitybetweenQ-Dandcontroleyeswasfoundinthelow dosegroup,carefulattentiontothepowerofthestudyis required,speciallyassumingthataclinicallyinsignificant changeinelectroretinographicactivitywouldbelessthana 20%differencebetweenwaveamplitudes. Therearesomeissuesthatremainunsolved.Itisunknown whetherdosesbetween0.1mg/0.1mLand1mg/0.1mLare toxic.Thisshouldbeinterestingsincesuccessfullytreated casesofendophthalmitismanagedwithQ-Dfallwithinthis doserange [5] [6] .Furtheranimalstudiesmaybenecessaryto determinethisfactor.However,basedontheseresultsand whathasbeenpreviouslyreported,itseemsthatthewindow ofQ-Dintraoculartoxicitymightnotbeasnarrowasother antibioticsthathavebeenadministeredintothevitreoussuch asamikacin.Whetherthesedoseshaveanadequate antibacterialactivitywiththelevelsreachedinthevitreous cavity,retinaandchoroidalsoremainstobedetermined. FurtherstudieswillalsobeneededontheQ-Dminimum inhibitoryconcentrations ,followedbyanimal inducedendophthalmitismodelstoproveitssafetyand efficacyaswellasitspharmacokineticcharacteristics. AnotherquestionarisingwiththeuseofQ-Dininfectious endophthalmitisiswhethercombiningitwithother antibioticsmightprovideadditionalbenefits.Thisissue shouldalsobeaddressedinfurtherstudiessinceithas alreadybeenconfirmedinothersystemicinfections [4] . Comparativeanimalendophthalmitismodelstudiesalsoneed tobeconductedwithstandardintravitrealantibioticssuchas vancomycinandceftazidime.Theseissuesneedtobe addressedinordertofurtherassesstheroleofintravitreal Q-Dinhumanbacterialendophthalmitis.
